Article info
PDFReview
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
- Correspondence to Professor David Lomas, Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK; dal16{at}cam.ac.uk
Citation
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
Publication history
- Received March 12, 2012
- Accepted May 30, 2012
- First published June 28, 2012.
Online issue publication
September 01, 2022
Article Versions
- Previous version (30 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode